Navigation Links
Strategies to control TB outdated, inadequate
Date:8/1/2008

The standard regimens to treat tuberculosis (TB) are inadequate in countries with high rates of multi-drug resistant (MDR) TB. In countries with high rates of MDR-TB, patients are nearly twice as likely to fail their initial treatment than those in countries with low rates, according to a new analysis of World Health Organization (WHO) data. This finding suggests strongly that current TB treatment regimens need to updated and revised to address the shifting landscape of public health in the face of MDR-TB.

"In countries with low prevalence of initial multi-drug resistance, the standardized treatment regimens for new case appear to be adequate, wrote Dick Menzies, M.D., lead author of the study and director of the respiratory division at McGill University. "However, in countries where the prevalence of initial drug resistance exceeds three percent, we believe it is urgent to strengthen capacity to perform drug sensitivity testing, or to reevaluate these standard treatment regimens, given the unacceptably high rates of failure and relapse."

The study appeared in the first issue for August of the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

When the current public health strategies to contain TB were conceived, MDR-TB was much less common. "We hypothesized that, in countries using standardized initial and retreatment regimens, the proportion of patients with poor treatment outcomes would be correlated with prevalence of initial and acquired multi-drug resistance," wrote Dr. Menzies.

To determine if that were the case, Dr. Menzies and co-investigators reviewed the WHO's data from 2003 and 2004 for a total of 155 countries, 121 of which reported at least 250 cases annually. They assessed dropout, failure, relapse and death rates with initial treatment, as well as dropout, failure and death rates for retreatment. All rates were analyzed with respect to the prevalence of MDR-TB in each country.

They were right: rates of failed treatment were dramatically higher with increasing prevalence of MDR-TB (p<0.0001). In fact, after accounting for age, HIV prevalence, per capita income and treatment regimen, for every one-percent increase in MDR TB prevalence, they saw a 0.30 percent rise in treatment failure among new cases, a 1.1 percent increase in failure rate among RE-treatment cases, and a one percent increase in relapse. "This is striking evidence that MDR-TB is directly linked to the increased failure rates of our current treatment regimens," said Dr. Menzies.

Overall, the proportion of patients requiring retreatment nearly doubled between countries with low and high prevalence of MDR-TB, from 11.9 percent in countries with initial MDR prevalence of less than one percent, to 21.4 percent in countries with MDR prevalence of more than three percent. "In the short term, the higher the failure and relapse rates mean greater morbidity and mortality for patients, with greater social and economic harm for their families and communities. In the long term, these standardized regimens may be contributing to amplification of multi-drug resistance in these countries," wrote Dr. Menzies.

The concern is that with current treatment regimens, many patients fail treatment or relapse later, and by continuing to use those regimens, researchers and public health officials may be unwittingly increasing the problem of drug resistance and multiplying the problem for other future patients. "Unless those with the responsibility to boost control and research efforts increase their commitments and their financial investments by several fold, we may never see elimination of this major scourge in the decades to come," wrote Marcos Espinal, M.D., and Mario C. Raviglione, M.D., both of the WHO, in an accompanying editorial in the same issue of the journal.


'/>"/>

Contact: Keely Savoie
ksavoie@thoracic.org
212-315-8620
American Thoracic Society
Source:Eurekalert

Related medicine news :

1. AAPPO Launches Short Course Conference Call Series on Value-added Strategies for PPOs
2. New Research on Genetic Changes in Melanomas and Teens Use of Indoor Tanning Could Lead to Better Prevention and Treatment Strategies
3. 2 different breast cancer screening strategies are equally effective
4. 2 Breast Cancer Screening Strategies Prove Effective
5. U.S. Preventive Medicine: Knowing Risk Factors & Early Detection are Best Strategies for Colon Cancer Prevention
6. Eularis Analyzes Most Effective Generics Defense Strategies With New Pharmaceutical Industry Report
7. Avalere Examines Emerging Strategies for Managing Imaging Utilization
8. Cord Blood America CEO Matthew Schissler Details Aggressive Expansion Strategies in U.S. and Europe
9. Older workforce requires variety of recruitment strategies
10. NYU, Rutgers study shows how using mental strategies can alter the brains reward circuitry
11. Aegis Health Group Revealed Next Generation of Employer-Based Health-Improvement Strategies at Nashville Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2017)... ... August 20, 2017 , ... Are you an adult ... If so, you may be interested in participating in a research study that ... research is to understand more about the relational aspects of adults who have gluten ...
(Date:8/19/2017)... (PRWEB) , ... August 19, 2017 , ... ... announced that it is the first organization with pending recognition status from the ... Prevention Program (“DPP”) via group telehealth classes and live video conferencing. , ...
(Date:8/19/2017)... ... August 19, 2017 , ... Physician Partners of America ... as an interventional pain management physician. He brings a wealth of pain management ... headaches, and significant experience in spinal cord stimulation for chronic pain. , Dr. ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... specialized asset-light logistics provider of complex transport solutions for mission-critical and non-discretionary ... Unitrans International Corporation, a division of Roadrunner Transportation Systems, Inc. (NYSE: RRTS). ...
(Date:8/18/2017)... ... ... The Dawn Johnson Insurance Group, a Missouri-based insurance and financial planning firm ... for efforts to educate the local population on cancer realities while attracting donations to ... , Each day in America, roughly 4,600 new cases of cancer are diagnosed and ...
Breaking Medicine News(10 mins):
(Date:8/17/2017)... Bio-Ess Laboratories, LLC Chief Science Officer, Dr. Adam Elhofy ... data on Cell-Ess® Universal Titer Boost at the 9 th ... August 21-25.  The Bioprocessing Summit convenes more than 1,000 international bioprocess ... ... Cell-Ess ...
(Date:8/15/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO), is now ... residents. Naloxone is available without a ... pharmacy, G-3320 Beecher Road. ... Administration, is intended to block or reverse the effects ... of consciousness. The medication is often carried by first ...
(Date:8/15/2017)... N.C. , Aug. 15, 2017 AccuGenomics, ... NC , today announced that the company has ... the University of North Carolina at Chapel Hill and ... is designed to characterize and quantify HIV reservoir and ... after pharmacological intervention. The HIV Cure Center is a ...
Breaking Medicine Technology: